SCHEMBL19855072

SCHEMBL19855072

C=C(CO)C(=O)OCCOc1ccc(-c2ccc(C3CCC(CCCCC)CC3)c(C)c2)cc1OCCOC(=O)C(=C)CO

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 3/20 0.36
▸ FPR2 P25090 1/20 0.34
▸ RARB P10826 1/20 0.33
▸ PTPN11 Q06124 4/20 0.33
▸ FFAR4 Q5NUL3 1/20 0.33
▸ CNR2 P34972 2/20 0.32
▸ CNR1 P21554 1/20 0.32
▸ PDE4A P27815 1/20 0.32
▸ PDE4B Q07343 1/20 0.32
▸ PDE4C Q08493 1/20 0.32
▸ PDE4D Q08499 1/20 0.32
▸ OPRL1 P41146 1/20 0.31
▸ PTPN1 P18031 1/20 0.31
▸ PTPN6 P29350 1/20 0.31
▸ GRIK2 Q13002 1/20 0.31
▸ HPGD P15428 1/20 0.30
▸ ALDH1A1 P00352 1/20 0.30
▸ TSHR P16473 1/20 0.30
▸ RAB9A P51151 1/20 0.30
▸ PTGES O14684 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19853860 0.93 FFAR4 (0.37) PPARGFPR2RARBPTPN11FFAR4
SCHEMBL19855083 0.92 FFAR4 (0.34) PPARGFPR2FFAR4PDE4APDE4B
SCHEMBL19855087 0.91 PPARG (0.36) PPARGFPR2PTPN11CNR2CNR1
SCHEMBL19855095 0.91 FFAR4 (0.33) FFAR4PDE4APDE4BPDE4CPDE4D
SCHEMBL19853843 0.89 CYP2C9 (0.36) PPARGFPR2PTPN11PDE4APDE4B
SCHEMBL19855086 0.89 CYP2C9 (0.36) PPARGFPR2PTPN11PDE4APDE4B
SCHEMBL19853858 0.88 PTPN11 (0.37) PPARGFPR2PTPN11PDE4APDE4B
SCHEMBL19722369 0.87 RARB (0.36) PPARGRARBPTPN11PTPN1PTPN6
SCHEMBL20313600 0.86 FFAR4 (0.32) FFAR4OPRL1
SCHEMBL19853850 0.86 FFAR4 (0.36) FFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210214615-A1 LIQUID CRYSTAL DISPLAY DEVICE AND DISPLAY UNIT JNC CORPORATION (JP) 2021-07-15 — — US disclosed
EP-3351525-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT JNC Corporation (JP) 2018-07-25 — — EP disclosed
US-20180179443-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-06-28 — — US disclosed
US-20180179443-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-06-28 — — US disclosed
WO-2018025974-A1 LIQUID-CRYSTAL DISPLAY ELEMENT AND DISPLAY DEVICE JNC株式会社 2018-02-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180179443-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE C1S, CCND1, C5 PPARG 2686/4885FPR2 945/4885RARB 3791/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback